EMBO Molecular Medicine, 1757-4684

Journal

More filtering options
  1. Amyloid blood biomarker detects Alzheimer's disease

    Andreas Nabers, Laura Perna, Julia Lange, Ute Mons, Jonas Schartner, Jörn Güldenhaupt, Kai Uwe Saum, Shorena Janelidze, Bernd Holleczek, Dan Rujescu, Oskar Hansson, Klaus Gerwert & Hermann Brenner, 2018, In: EMBO Molecular Medicine. 10, 5, e8763.

    Research output: Contribution to journalArticle

  2. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

    Sebastian Palmqvist, Philip S. Insel, Erik Stomrud, Shorena Janelidze, Henrik Zetterberg, Britta Brix, Udo Eichenlaub, Jeffrey L. Dage, Xiyun Chai, Kaj Blennow, Niklas Mattsson & Oskar Hansson, 2019 Dec 1, In: EMBO Molecular Medicine. 11, 12, e11170.

    Research output: Contribution to journalArticle

  3. Alternative oxidase-mediated respiration prevents lethal mitochondrial cardiomyopathy

    Jayasimman Rajendran, Janne Purhonen, Saara Tegelberg, Olli Pekka Smolander, Matthias Mörgelin, Jan Rozman, Valerie Gailus-Durner, Helmut Fuchs, Martin Hrabe de Angelis, Petri Auvinen, Eero Mervaala, Howard T. Jacobs, Marten Szibor, Vineta Fellman & Jukka Kallijärvi, 2018, In: EMBO Molecular Medicine. 2018, e9456.

    Research output: Contribution to journalArticle

  4. Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation

    Ina Rohwedder, Eloi Montanez, Karsten Beckmann, Eva Bengtsson, Pontus Dunér, Jan Nilsson, Oliver Soehnlein & Reinhard Faessler, 2012, In: EMBO Molecular Medicine. 4, 7, p. 564-576

    Research output: Contribution to journalArticle

Previous 1 2 Next